Zou W, Zhang J, Li Y, Cao Y, Li J, Zhang Z
BMC Pulm Med. 2025; 25(1):122.
PMID: 40089712
DOI: 10.1186/s12890-025-03524-0.
Heydemann L, Ciurkiewicz M, Stork T, Zdora I, Hulskotter K, Gregor K
Nat Commun. 2025; 16(1):2080.
PMID: 40021627
PMC: 11871369.
DOI: 10.1038/s41467-025-57267-x.
Shabani M, Nejati A, Yavarian J, Sadeghi K, Zadheidar S, Ahmadi A
Front Microbiol. 2025; 15:1531712.
PMID: 39943963
PMC: 11815659.
DOI: 10.3389/fmicb.2024.1531712.
Themlaoui A, Ancora M, Ghedira K, Mhalla Y, Hamdoun M, Bahri M
Viruses. 2025; 17(1).
PMID: 39861838
PMC: 11768452.
DOI: 10.3390/v17010046.
Ignuta F, Vlad A, Cerbulescu T, Loredana S, Bratosin F, Rosca O
Biomedicines. 2025; 13(1.
PMID: 39857695
PMC: 11762707.
DOI: 10.3390/biomedicines13010111.
Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report.
Miyata Y, Yamaguchi R, Yamamoto T, Kishida T, Ikeuchi K, Harada H
J Pharm Health Care Sci. 2025; 11(1):3.
PMID: 39844338
PMC: 11756168.
DOI: 10.1186/s40780-025-00411-y.
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2.
Colaneri M, Canuti M, Torrigiani G, DallOlio L, Bobbio C, Baldi S
Infect Dis Ther. 2025; 14(2):447-461.
PMID: 39838255
PMC: 11829856.
DOI: 10.1007/s40121-024-01107-w.
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters.
Da Silva Antunes R, Fajardo-Rosas V, Yu E, Galvez R, Abawi A, Escarrega E
bioRxiv. 2025; .
PMID: 39829792
PMC: 11741356.
DOI: 10.1101/2025.01.08.631842.
Adaptive evolution of SARS-CoV-2 during a persistent infection for 521 days in an immunocompromised patient.
Schmidt H, Schick L, Podlech J, Renzaho A, Lieb B, Diederich S
NPJ Genom Med. 2025; 10(1):4.
PMID: 39820045
PMC: 11739519.
DOI: 10.1038/s41525-025-00463-x.
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review.
Hirsch C, Kreuzberger N, Skoetz N, Monsef I, Kluge S, Spinner C
J Antimicrob Chemother. 2025; 80(3):633-644.
PMID: 39804238
PMC: 11879234.
DOI: 10.1093/jac/dkae482.
Impact of Prolonged SARS-CoV-2 Viral Shedding on COVID-19 Disease Outcome and Viral Dynamics.
Sanyaolu A, Marinkovic A, Prakash S, Balendra V, Hamdy K, Haider N
Indian J Microbiol. 2024; 64(4):1416-1424.
PMID: 39678987
PMC: 11645332.
DOI: 10.1007/s12088-024-01238-1.
Differential Impact of Spike Protein Mutations on SARS-CoV-2 Infectivity and Immune Evasion: Insights from Delta and Kappa Variants.
Kim T, Bae S, Myoung J
J Microbiol Biotechnol. 2024; 34(12):2506-2515.
PMID: 39631784
PMC: 11733546.
DOI: 10.4014/jmb.2411.11001.
The consequences of SARS-CoV-2 within-host persistence.
Sigal A, Neher R, Lessells R
Nat Rev Microbiol. 2024; .
PMID: 39587352
DOI: 10.1038/s41579-024-01125-y.
Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, China.
Shen X, Jiang Y, Li S, Xie X, Cheng Y, Wu L
Brain Behav Immun Health. 2024; 42:100889.
PMID: 39498382
PMC: 11532739.
DOI: 10.1016/j.bbih.2024.100889.
No evidence that mutations in SARS-CoV-2 variants of concern derive from homologous fragments in gut microbiota.
Parry R, Lytras S, Petrone M, Wille M, Crits-Christoph A, Gifford R
J Virol. 2024; 98(12):e0146824.
PMID: 39494907
PMC: 11650967.
DOI: 10.1128/jvi.01468-24.
Diagnostic Utility of SARS-CoV-2 Nucleocapsid Antigenemia: A Meta-analysis.
Damhorst G, Martin S, Wilber E, Verkerke H, Goodman M, Lam W
Open Forum Infect Dis. 2024; 11(10):ofae561.
PMID: 39431150
PMC: 11487748.
DOI: 10.1093/ofid/ofae561.
In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing .
Arevalo-Romero J, Lopez-Cantillo G, Moreno-Jimenez S, Marcos-Alcalde I, Ros-Pardo D, Camacho B
Int J Mol Sci. 2024; 25(19).
PMID: 39409131
PMC: 11476394.
DOI: 10.3390/ijms251910802.
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection.
Schoefbaenker M, Gunther T, Lorentzen E, Romberg M, Hennies M, Neddermeyer R
PLoS Pathog. 2024; 20(10):e1012624.
PMID: 39405332
PMC: 11508484.
DOI: 10.1371/journal.ppat.1012624.
Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection.
Moussaoui M, Bontems S, Meex C, Hayette M, Lejeune M, Hong S
Virus Evol. 2024; 10(1):veae073.
PMID: 39399151
PMC: 11470753.
DOI: 10.1093/ve/veae073.
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19.
Singh K, Rocco J, Nussenblatt V
Semin Hematol. 2024; 61(5):321-332.
PMID: 39379249
PMC: 11626729.
DOI: 10.1053/j.seminhematol.2024.08.002.